Evidence map›Paper›PMID 42465755›Full record

ReviewFrontiers in immunology2026

Beyond density: mapping the functional landscapes of macrophage-T lymphocyte niches in the tumor microenvironment.

Serena Zilio, Adrien Rouault Montecino, Malvina Seradj, Ilaria Marigo, Armelle Prévost-Blondel, Elisa Peranzoni, Nadège Bercovici

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Serena Zilio *Immunology and Molecular Oncology Diagnostics, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
Adrien Rouault Montecino *Université Paris Cité, CNRS, Inserm, Institut Cochin, Paris, France.
Malvina Seradj *Université Paris Cité, CNRS, Inserm, Institut Cochin, Paris, France.
Ilaria MarigoImmunology and Molecular Oncology Diagnostics, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
Armelle Prévost-BlondelUniversité Paris Cité, CNRS, Inserm, Institut Cochin, Paris, France.
Elisa Peranzoni *Immunology and Molecular Oncology Diagnostics, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
Nadège Bercovici *Université Paris Cité, CNRS, Inserm, Institut Cochin, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The spatial arrangement of tumor-associated macrophages (TAMs) and T cells within distinct microanatomical niches is emerging as a key regulator of clinical outcome in solid tumors. Here, we propose a comprehensive review that integrates spatial insights with functional studies of macrophage and T cell heterogeneity, to elucidate how the physical crosstalk and the localization of these cells in the tumor microenvironment (TME) can impact the prognosis and the response to immunotherapy and, vice versa, how diverse immunotherapies can dynamically reshape the TME immune geography. We first review the heterogeneity of macrophages and tumor-infiltrating T lymphocytes (TILs) in TME, and the different types of TAM-TIL niches recently described by multidimensional proteomics and spatial transcriptomics, addressing their impact on tumor progression and response to immunotherapy. Building on our own work, we then dissect the anti-tumoral and pro-tumoral mechanisms operating in the different types of immune hubs. Next, we examine how tumor cues and therapeutic strategies can reprogram macrophages and T cells across functional and spatial dimensions, thereby promoting TME permissive to intraepithelial T cell infiltration and clinical response. Finally, we discuss how the integration of multi-omics and artificial intelligence are transitioning immuno-oncology from a cell-centric to a niche-centric paradigm, providing a roadmap for the design of next-generation therapies that precisely reprogram cellular dialogues within the tumor microenvironment.

Indexed as

Lymphocytes, Tumor-InfiltratingMacrophagesNeoplasmsT-LymphocytesTumor-Associated MacrophagesTumor MicroenvironmentAnimalsHumansImmunotherapySpatial Transcriptomicscellular neighborhoodimmune cell crosstalkspatial biologyTAM-TIL nichestumor-associated macrophages (TAMs)tumor-infiltrating T lymphocytes (TILs)tumor microenvironment (TME)

Identifiers

PMID42465755
PMCPMC13373503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.